Protecting HTC Data Requires Reading the Fine Print
By Mike Glomb and Elizabeth (Issie) Karan
Under the auspices of 340B Program compliance, manufacturers recently requested extensive data from covered entities related to drugs dispensed through contract pharmacies. Two manufacturers, Merck and Sanofi, are using the same third-party vendor to gather, deidentify, and transmit the data. The platform is called 340B ESP and is operated by a Silicon Valley startup, Second Sight Solutions (Second Sight).
Also in this Issue…
Notes from Joe
· Not Quite at the Finish Line Yet
· Welcome Kimberly Lackman, the Newest Alliance Employee!
· Payer Relations Update
· Alliance, NHF and HFA Launch the Harmony in Hemophilia Campaign
Notes from the Community
· Announcing Year 1 of Hemophilia Alliance Foundation Large Grant Award Winners